The FDA withdraws metformin for treating diabetes … Know the reason

Cairo – by Mohamed Salah – The US Food and Drug Administration announced FDA This week, the diabetes drug metformin hydrochloride was withdrawn because it contains excessive levels of the carcinogen.

According to a report by the American “New York Post”, the company Marksans Pharma Limited The drug manufacturer is expanding the recall that was initially announced in June to now include 76 additional quantities of expired drugs, as the recalled drugs are marketed as “extended-release tablets” under the brand name. Time-Cap Labs، Inc.

Withdrawal of a sugar medicine containing carcinogens

The drug helps lower blood glucose levels in patients with type 2 diabetes, but the recalled product contains an unacceptably high level of the substance N-Nitrosodimethylamine , Which is considered a possible human carcinogen.

Advertisements

The Food and Drug Administration stated in its advertisement, “The company has leased Marksans Exam N-Nitrosodimethylamine (NDMA) For unfinished marketed pieces specified and noted material content NDMA (In some parts, the acceptable daily intake is exceeded)NAME) Of 96 ng / day, therefore, out of extreme caution, an additional 76 pieces were withdrawn.

Recalling applies to metformin tablets between 500 mg and 750 mg, and tablets of 500 mg with “101” inscribed on one side.

The Food and Drug Administration advises (FDAThe users continue to take the withdrawn tablets until a medical professional provides an alternative or alternative treatment option.

“It may be dangerous for people with type 2 diabetes to stop taking metformin without first talking to a healthcare professional,” the Food and Drug Administration said in a statement.

Consumers should “contact their physician or health care provider if they encounter any problems that may be related to the intake or use of this medicinal product.”